Taviss Pharma Private Limited

Taviss Pharma Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2014PTC093187 Incorporated 26 February 2014 ROC Hyderabad HQ Secunderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹52.82 Lakh
▲ 24% YoY
Net profit · FY 2024
₹1.34 Lakh
Net margin 2.5%
EBITDA · FY 2024
₹1.58 Lakh
EBITDA margin 3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
2
of 5 registered

About Taviss Pharma Private Limited

Data last updated:

Taviss Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 February 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC093187. Its GSTIN is 36AAHFT7098N1Z8 (Telangana). The company holds 5 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Surekha Sadasivapet and Tharun Kande.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Secunderabad, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹52.82 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.34 Lakh (net margin 2.5%) and EBITDA of ₹1.58 Lakh (EBITDA margin 3%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Taviss Pharma Private Limited
CIN U24232TG2014PTC093187
Registration Number 093187
Incorporation Date 26 February 2014
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN History of Taviss Pharma Private Limited

Taviss Pharma has one previous CIN (Corporate Identification Number): U24232AP2014PTC093187. The current CIN is U24232TG2014PTC093187, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2014PTC093187Current
U24232AP2014PTC093187Previous
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    House No. 02 – 133/2/66 Flat No 403 Sai Gautami Residency Spring Fields Je, Edimetla, Secunderabad, Telangana, India – 500055
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Taviss Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Taviss Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Taviss Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Taviss Pharma Private Limited

The main business activity of Taviss Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Taviss Pharma Private Limited FY 2025 filings available

Taviss Pharma Private Limited reported revenue of ₹52.82 Lakh (up 24% YoY) for FY 2024.

Revenue · FY 2024
₹52.82 Lakh ▲ 24%
Net profit · FY 2024
₹1.34 Lakh margin 2.5%
EBITDA · FY 2024
₹1.58 Lakh margin 3%

Compounded Annual Growth Rate (CAGR) of Taviss Pharma Private Limited

Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 18%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 11%
5 years · compounded
▼ 29%

Revenue rose 24% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Taviss Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.58 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.34 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Taviss Pharma Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3%••••••••••••••••
Net Profit Margin2.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Taviss Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Taviss Pharma Private Limited

Taviss Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Surekha SadasivapetDirector26 Feb 201412 Years 7 MonthsCurrent
Tharun KandeAdditional Director24 Nov 20196 Years 10 MonthsCurrent

Peer Comparison of Taviss Pharma Private Limited

Taviss Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Athanasius Pharma Private Limited₹53.12 Lakh (FY 2025)••••••••-21.0%••••Delhi, India
Amsky Pharma Private Limited₹53 Lakh (FY 2025)••••••••19.0%••••Panchkula, Haryana, India
Axonav Pharma Private Limited₹52.98 Lakh (FY 2018)••••••••-27.0%••••Ghaziabad, Uttar Pradesh, India
Viti Healthcare Private Limited₹52.98 Lakh (FY 2025)••••••••-19.0%••••Haryana, India
Shorya Sakshi Contractors Private Limited₹52.97 Lakh (FY 2024)••••••••438.0%••••Gurugram, Haryana, India
Taviss Pharma Private Limited this company₹52.82 Lakh (FY 2024)••••••••24.0%••••Secunderabad, Telangana, India
Surbhee Industrial Products Private Limited₹52.81 Lakh (FY 2025)••••••••275.0%••••Delhi, India
K L Fincon Private Limited₹52.78 Lakh (FY 2021)••••••••26.0%••••Malakunta Road, Telangana, India
RVT Pharma Enterprises Private Limited₹52.78 Lakh (FY 2025)••••••••••••Nagpur, Maharashtra, India
Ameliorate Pharmacare Private Limited₹52.73 Lakh (FY 2024)••••••••-74.0%••••Bengaluru, Karnataka, India
Gaba Pharmaceuticals Private Limited₹52.67 Lakh (FY 2024)••••••••16.0%••••Medchal, Telangana, India

Peers are the five companies nearest above and the five nearest below Taviss Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Taviss Pharma Private Limited

Taviss Pharma Private Limited is audited by REVENUE & ASSOCIATES for the financial year 2020.

NameStatusAppointment DateCessation Date
REVENUE & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Taviss Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Taviss Pharma Private Limited

Taviss Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Taviss Pharma Private Limited

Employment history and EPFO contributions of people linked to Taviss Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Taviss Pharma Private Limited

Taviss Pharma Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Bhavani Tekula ceased to be Director on 25 Nov 2019.

AGM
Taviss Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Taviss Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Bhavani Tekula ceased to be Director.
Appointed
Tharun Kande was appointed as Additional Director.
Appointed
Surekha Sadasivapet was appointed as Director.
Incorporation
26 Feb 2014
Taviss Pharma Private Limited was registered on 26 Feb 2014 with Roc Hyderabad & aged 12 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Taviss Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Taviss Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Taviss Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Taviss Pharma Private Limited

Taviss Pharma has 5 GST registrations: 2 active and 3 cancelled or inactive.

Total GSTINs
5
Active
2
Cancelled / inactive
3
GSTINStateStatusRegistered on
36AAHFT7098N1Z8TelanganaActive01 Jul 2017
29AAHFT7098N2Z2KarnatakaActive04 May 2018
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Taviss Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Taviss Pharma Private Limited

Taviss Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 February 2014 (12+ years old) and is registered under CIN U24232TG2014PTC093187.

Taviss Pharma reported revenue of ₹52.82 Lakh for FY 2024 (up 24% YoY).

Taviss Pharma has 2 current directors:

Taviss Pharma reported a net profit of ₹1.34 Lakh (net margin 2.5%) and EBITDA of ₹1.58 Lakh (EBITDA margin 3%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Taviss Pharma is 18% over three years and -12% over five years. In the latest year (FY 2024) revenue rose 24%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Taviss Pharma is 36AAHFT7098N1Z8, registered in Telangana. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 29AAHFT7098N2Z2 (Karnataka).

The CIN (Corporate Identification Number) of Taviss Pharma is U24232TG2014PTC093187. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Taviss Pharma was incorporated on 26 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Taviss Pharma by revenue are Athanasius Pharma Private Limited, Amsky Pharma Private Limited, Axonav Pharma Private Limited, Viti Healthcare Private Limited, Shorya Sakshi Contractors Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Bhavani Tekula ceased to be Director on 25 Nov 2019. Tharun Kande was appointed as Additional Director on 24 Nov 2019. Surekha Sadasivapet was appointed as Director on 26 Feb 2014.

The registered office of Taviss Pharma is at House No. 02 – 133266 Flat No 403 Sai Gautami Residency Spring Fields Je, Edimetla, Secunderabad, Telangana, India – 500055.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available